Prof Dr med. Hortense Slevogt

Prof Dr med. Hortense Slevogt
Head of Research Group

Prof Dr med Hortense Slevogt has established herself as a distinguished researcher and physician in the fields of respiratory infections and immunology. Her academic journey began with a degree in medicine at Freie Universität Berlin, during which she developed a particular interest in infectious diseases and their impact on respiratory health. Driven by her passion for understanding the intricate workings of the human immune system, she pursued further specialization in Internal Medicine and Pulmonology, becoming a recognized expert in the field.

In 2009, Prof Slevogt's achievements were acknowledged through the completion of her habilitation in Internal Medicine at Charité - Universitätsmedizin Berlin. This significant milestone marked her expertise and profound understanding of the intricate nature of severe infections. A few years later, in 2011, Prof. Slevogt assumed the leadership of the Host Septomics Group at Universitätsklinikum Jena.

In 2022, she obtained the W3-Professorship at Medizinische Hochschule Hannover (MHH) and became the Head of the Research Group "Respiratory Infection Dynamics" (DINF) at the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Her role entails spearheading translational projects that involve collaborations with esteemed academic and medical partners at the MHH. Through these endeavors, Dr Slevogt investigates host-pathogen interactomes and elucidates the mechanisms underlying immune responses and their control.

In parallel to her research pursuits, Dr Slevogt remains dedicated to clinical practice, ensuring that her findings directly benefit patients. She serves as the Senior Consultant in Clinical Infectiology at the Department of Respiratory Medicine and Infectious Diseases (MHH), contributing her expertise to the diagnosis and treatment of respiratory infections.

Publications
Kramer A., Borg Dahl M., Bengtsson M.M., Boyce J.M., Heckmann M., Meister M., Papke R., Pittet D., Reinhard A., Slevogt H., Wang H., Zwicker P., ... , Urich T., Seifert U. (2024)
No detrimental effect on the hand microbiome of healthcare staff by frequent alcohol-based antisepsis
Am.J.Infect.Control

Ringshausen F.C., Baumann I., Roux A., Dettmer S., Diel R., Eichinger M., Ewig S., Flick H., Hanitsch L., Hillmann T., Koczulla R., Köhler M., Koitschev A., Kugler C., Nüßlein T., Ott S.R., Pink I., Pletz M., Rohde G., Sedlacek L., Slevogt H., Sommerwerck U., Sutharsan S., Weihe S., Welte T., Wilken M., ... , Rademacher J., Mertsch P. (2024)
Management of adult bronchiectasis - Consensus-based Guidelines for the German Respiratory Society (DGP) e. V. (AWMF registration number 020-030)
Pneumologie (Stuttgart, Germany), 78 (11)

Timme S., Wendler S., Klassert T.E., Saraiva J.P., da Rocha U.N., Wittchen M., Schramm S., Ehricht R., Monecke S., Edel B., Rödel J., Löffler B., Ramirez M.S., Slevogt H., ... , Figge M.T., Tuchscherr L. (2024)
Competitive inhibition and mutualistic growth in co-infections: deciphering Staphylococcus aureus-Acinetobacter baumannii interaction dynamics
ISME.Commun., 4 (1)

Gheitasi R., Röll D., Müller M.M., Naseri M., König R., Slevogt H., ... , Pletz M.W., Makarewicz O. (2024)
Exploring secretory proteome and cytokine kinetic of human peripheral blood mononuclear cells exposed to methicillin-resistant Staphylococcus aureus biofilms and planktonic bacteria
Frontiers in Immunology, 15

Truthe S., Klassert T.E., Schmelz S., Jonigk D., Blankenfeldt W., Slevogt H. (2024)
Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Inflammation and Pathogen-Associated Interactions
Journal of Innate Immunity, 16 (1)

Hinze C.A., Fuge J., Grote-Koska D., Brand K., Slevogt H., Cornberg M., Simon S., Joean O., ... , Welte T., Rademacher J. (2024)
Factors influencing voriconazole plasma level in intensive care patients
JAC-Antimicr.Res., 6 (2)

Klassert T.E., Zubiria-Barrera C., Denkel L., Neubert R., Schneegans A., Kulle A., Vester A., Bloos F., Schulze C., Epstude J., Gastmeier P., ... , Geffers C., Slevogt H. (2024)
Skin dysbiosis and loss of microbiome site specificity in critically ill patients
Microbiol.Spectr.

Ahrenstorf G., Dopfer-Jablonka A., Joean O., Knuth C., Silchmueller M., Thiele T., Ringshausen F.C., Slevogt H., ... , Witte T., Behrens G.M.N. (2023)
Status of HIV and comorbidities in refugees with HIV from Ukraine
HIV Med.

Klassert T.E., Hölzer M., Zubiria-Barrera C., Bethge J., Klaile E., Müller M.M., ... , Marz M., Slevogt H. (2023)
Differential Transcriptional Responses of Human Granulocytes to Fungal Infection with Candida albicans and Aspergillus fumigatus
J Fungi.(Basel), 9 (10)

Riebold D., Mahnkopf M., Wicht K., Zubiria-Barrera C., Heise J., Frank M., Misch D., Bauer T., ... , Stocker H., Slevogt H. (2023)
Axenic Long-Term Cultivation of Pneumocystis jirovecii
J.Fungi, 9 (9)

Refisch A., Sen Z.D., Klassert T.E., Busch A., Besteher B., Danyeli L.V., Helbing D., Schulze-Späte U., Stallmach A., Bauer M., Panagiotou G., Jacobsen I.D., Slevogt H., ... , Opel N., Walter M. (2023)
Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation
Neuropharmacology, 235 (September 2023)

Maurer M., Klassert T.E., Löffler B., Slevogt H., Tuchscherr L. (2023)
Extraction of High-Quality RNA from S. aureus Internalized by Endothelial Cells
Microorganisms., 11 (4)